NU SKIN ENTERPRISES INC - A (NUS) Stock Fundamental Analysis
USA - NYSE:NUS - US67018T1051 - Common Stock
10.72 USD
+0.1 (+0.94%)
10.72 USD
0 (0%)
We assign a fundamental rating of 5 out of 10 to NUS. NUS was compared to 34 industry peers in the Personal Care Products industry. NUS is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. NUS is valued quite cheap, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year NUS was profitable.
In the past year NUS had a positive cash flow from operations.
Of the past 5 years NUS 4 years were profitable.
In the past 5 years NUS always reported a positive cash flow from operatings.
1.2 Ratios
With a decent Return On Assets value of 6.98%, NUS is doing good in the industry, outperforming 67.65% of the companies in the same industry.
NUS's Return On Equity of 12.80% is fine compared to the rest of the industry. NUS outperforms 79.41% of its industry peers.
NUS has a Return On Invested Capital (3.88%) which is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for NUS is significantly below the industry average of 12.77%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.98% | ||
| ROE | 12.8% | ||
| ROIC | 3.88% |
ROA(3y)-1.25%
ROA(5y)2.75%
ROE(3y)-3.26%
ROE(5y)5.55%
ROIC(3y)5.22%
ROIC(5y)9.29%
1.3 Margins
Looking at the Profit Margin, with a value of 6.20%, NUS is in the better half of the industry, outperforming 70.59% of the companies in the same industry.
NUS has a Operating Margin of 3.51%. This is comparable to the rest of the industry: NUS outperforms 47.06% of its industry peers.
In the last couple of years the Operating Margin of NUS has declined.
NUS has a Gross Margin of 67.23%. This is comparable to the rest of the industry: NUS outperforms 50.00% of its industry peers.
NUS's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 3.51% | ||
| PM (TTM) | 6.2% | ||
| GM | 67.23% |
OM growth 3Y-34.86%
OM growth 5Y-23.31%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.08%
GM growth 5Y-2.13%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), NUS is destroying value.
Compared to 1 year ago, NUS has more shares outstanding
The number of shares outstanding for NUS has been reduced compared to 5 years ago.
NUS has a better debt/assets ratio than last year.
2.2 Solvency
NUS has an Altman-Z score of 3.76. This indicates that NUS is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.76, NUS is in the better half of the industry, outperforming 64.71% of the companies in the same industry.
The Debt to FCF ratio of NUS is 0.61, which is an excellent value as it means it would take NUS, only 0.61 years of fcf income to pay off all of its debts.
NUS's Debt to FCF ratio of 0.61 is amongst the best of the industry. NUS outperforms 91.18% of its industry peers.
NUS has a Debt/Equity ratio of 0.27. This is a healthy value indicating a solid balance between debt and equity.
NUS has a Debt to Equity ratio (0.27) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.27 | ||
| Debt/FCF | 0.61 | ||
| Altman-Z | 3.76 |
ROIC/WACC0.52
WACC7.52%
2.3 Liquidity
A Current Ratio of 2.01 indicates that NUS has no problem at all paying its short term obligations.
NUS has a Current ratio (2.01) which is comparable to the rest of the industry.
A Quick Ratio of 1.38 indicates that NUS should not have too much problems paying its short term obligations.
The Quick ratio of NUS (1.38) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.01 | ||
| Quick Ratio | 1.38 |
3. Growth
3.1 Past
The earnings per share for NUS have decreased by -1.63% in the last year.
The earnings per share for NUS have been decreasing by -22.85% on average. This is quite bad
Looking at the last year, NUS shows a very negative growth in Revenue. The Revenue has decreased by -11.80% in the last year.
Measured over the past years, NUS shows a decrease in Revenue. The Revenue has been decreasing by -6.47% on average per year.
EPS 1Y (TTM)-1.63%
EPS 3Y-41.01%
EPS 5Y-22.85%
EPS Q2Q%104.76%
Revenue 1Y (TTM)-11.8%
Revenue growth 3Y-13.71%
Revenue growth 5Y-6.47%
Sales Q2Q%-12.06%
3.2 Future
NUS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 36.15% yearly.
Based on estimates for the next years, NUS will show a decrease in Revenue. The Revenue will decrease by -5.71% on average per year.
EPS Next Y49.72%
EPS Next 2Y36.15%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-11.95%
Revenue Next 2Y-5.71%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 8.86, the valuation of NUS can be described as reasonable.
Compared to the rest of the industry, the Price/Earnings ratio of NUS indicates a rather cheap valuation: NUS is cheaper than 91.18% of the companies listed in the same industry.
NUS's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.11.
NUS is valuated cheaply with a Price/Forward Earnings ratio of 6.80.
Based on the Price/Forward Earnings ratio, NUS is valued cheaper than 94.12% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.55, NUS is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.86 | ||
| Fwd PE | 6.8 |
4.2 Price Multiples
91.18% of the companies in the same industry are more expensive than NUS, based on the Enterprise Value to EBITDA ratio.
100.00% of the companies in the same industry are more expensive than NUS, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 1.29 | ||
| EV/EBITDA | 4.35 |
4.3 Compensation for Growth
NUS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as NUS's earnings are expected to grow with 36.15% in the coming years.
PEG (NY)0.18
PEG (5Y)N/A
EPS Next 2Y36.15%
EPS Next 3YN/A
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 2.26%, NUS has a reasonable but not impressive dividend return.
NUS's Dividend Yield is a higher than the industry average which is at 5.96.
Compared to an average S&P500 Dividend Yield of 2.37, NUS has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.26% |
5.2 History
The dividend of NUS decreases each year by -30.50%.
NUS has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-30.5%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
11.83% of the earnings are spent on dividend by NUS. This is a low number and sustainable payout ratio.
DP11.83%
EPS Next 2Y36.15%
EPS Next 3YN/A
10.72
+0.1 (+0.94%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)
Earnings (Next)
Inst Owners75.02%
Inst Owner Change-0.25%
Ins Owners2.08%
Ins Owner Change3.24%
Market Cap530.64M
Revenue(TTM)1.63B
Net Income(TTM)100.83M
Analysts45
Price Target7.65 (-28.64%)
Short Float %4.5%
Short Ratio3.99
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.26% |
Yearly Dividend0.24
Dividend Growth(5Y)-30.5%
DP11.83%
Div Incr Years0
Div Non Decr Years0
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)73.8%
Min EPS beat(2)73.77%
Max EPS beat(2)73.83%
EPS beat(4)3
Avg EPS beat(4)52.6%
Min EPS beat(4)-13.83%
Max EPS beat(4)76.64%
EPS beat(8)6
Avg EPS beat(8)40.86%
EPS beat(12)9
Avg EPS beat(12)30.24%
EPS beat(16)13
Avg EPS beat(16)24.81%
Revenue beat(2)2
Avg Revenue beat(2)2%
Min Revenue beat(2)1.5%
Max Revenue beat(2)2.51%
Revenue beat(4)3
Avg Revenue beat(4)0.44%
Min Revenue beat(4)-3.42%
Max Revenue beat(4)2.51%
Revenue beat(8)5
Avg Revenue beat(8)-0.53%
Revenue beat(12)5
Avg Revenue beat(12)-1.53%
Revenue beat(16)7
Avg Revenue beat(16)-1.15%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)4.9%
EPS NY rev (1m)0%
EPS NY rev (3m)27.02%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.58%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.27%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.86 | ||
| Fwd PE | 6.8 | ||
| P/S | 0.33 | ||
| P/FCF | 1.29 | ||
| P/OCF | 1.19 | ||
| P/B | 0.67 | ||
| P/tB | 0.81 | ||
| EV/EBITDA | 4.35 |
EPS(TTM)1.21
EY11.29%
EPS(NY)1.58
Fwd EY14.7%
FCF(TTM)8.3
FCFY77.44%
OCF(TTM)9
OCFY84%
SpS32.86
BVpS15.91
TBVpS13.3
PEG (NY)0.18
PEG (5Y)N/A
Graham Number20.82
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.98% | ||
| ROE | 12.8% | ||
| ROCE | 4.92% | ||
| ROIC | 3.88% | ||
| ROICexc | 5.04% | ||
| ROICexgc | 5.89% | ||
| OM | 3.51% | ||
| PM (TTM) | 6.2% | ||
| GM | 67.23% | ||
| FCFM | 25.27% |
ROA(3y)-1.25%
ROA(5y)2.75%
ROE(3y)-3.26%
ROE(5y)5.55%
ROIC(3y)5.22%
ROIC(5y)9.29%
ROICexc(3y)6.41%
ROICexc(5y)12.52%
ROICexgc(3y)8.32%
ROICexgc(5y)17.24%
ROCE(3y)6.61%
ROCE(5y)11.76%
ROICexgc growth 3Y-45.58%
ROICexgc growth 5Y-28.67%
ROICexc growth 3Y-42.83%
ROICexc growth 5Y-26.9%
OM growth 3Y-34.86%
OM growth 5Y-23.31%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.08%
GM growth 5Y-2.13%
F-Score6
Asset Turnover1.13
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.27 | ||
| Debt/FCF | 0.61 | ||
| Debt/EBITDA | 1.81 | ||
| Cap/Depr | 56.99% | ||
| Cap/Sales | 2.14% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 377.59% | ||
| Profit Quality | 407.56% | ||
| Current Ratio | 2.01 | ||
| Quick Ratio | 1.38 | ||
| Altman-Z | 3.76 |
F-Score6
WACC7.52%
ROIC/WACC0.52
Cap/Depr(3y)74.52%
Cap/Depr(5y)79.94%
Cap/Sales(3y)2.68%
Cap/Sales(5y)2.61%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1.63%
EPS 3Y-41.01%
EPS 5Y-22.85%
EPS Q2Q%104.76%
EPS Next Y49.72%
EPS Next 2Y36.15%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-11.8%
Revenue growth 3Y-13.71%
Revenue growth 5Y-6.47%
Sales Q2Q%-12.06%
Revenue Next Year-11.95%
Revenue Next 2Y-5.71%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y44.66%
EBIT growth 3Y-43.79%
EBIT growth 5Y-28.27%
EBIT Next Year155.65%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y21528.6%
FCF growth 3Y-1.31%
FCF growth 5Y-8.9%
OCF growth 1Y561.31%
OCF growth 3Y-7.59%
OCF growth 5Y-8.88%
NU SKIN ENTERPRISES INC - A / NUS FAQ
Can you provide the ChartMill fundamental rating for NU SKIN ENTERPRISES INC - A?
ChartMill assigns a fundamental rating of 5 / 10 to NUS.
Can you provide the valuation status for NU SKIN ENTERPRISES INC - A?
ChartMill assigns a valuation rating of 9 / 10 to NU SKIN ENTERPRISES INC - A (NUS). This can be considered as Undervalued.
Can you provide the profitability details for NU SKIN ENTERPRISES INC - A?
NU SKIN ENTERPRISES INC - A (NUS) has a profitability rating of 4 / 10.
What is the valuation of NU SKIN ENTERPRISES INC - A based on its PE and PB ratios?
The Price/Earnings (PE) ratio for NU SKIN ENTERPRISES INC - A (NUS) is 8.86 and the Price/Book (PB) ratio is 0.67.
Is the dividend of NU SKIN ENTERPRISES INC - A sustainable?
The dividend rating of NU SKIN ENTERPRISES INC - A (NUS) is 4 / 10 and the dividend payout ratio is 11.83%.